Login / Signup

Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.

Nuramalina H MuminNeele DrobnitzkyAgata PatelLuiza Madia LourencoFiona F CahillYanyan JiangAnthony KongAnderson J Ryan
Published in: BMC cancer (2019)
Acquired resistance to HSP90i in TNBC cells is associated with an upregulated JAK-STAT signalling pathway. A combined inhibition of the JAK-STAT signalling pathway and HSP90 could overcome this resistance. The benefits of the combined therapy could be explored further for the development of effective targeted therapy in TNBC patients.
Keyphrases